Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-35.87M
↓ 37% below average
Average (9y)
$-26.26M
Historical baseline
Range
High:$-15.66M
Low:$-37.60M
CAGR
+8.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-35.87M | +4.6% |
| 2023 | $-37.60M | -41.5% |
| 2022 | $-26.58M | +24.3% |
| 2021 | $-35.10M | -44.5% |
| 2020 | $-24.29M | -55.1% |
| 2019 | $-15.66M | +32.9% |
| 2018 | $-23.35M | -4.3% |
| 2017 | $-22.39M | +6.6% |
| 2016 | $-23.96M | -34.9% |
| 2015 | $-17.76M | - |